Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Gastroesophageal Reflux Disease
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 19 years and 50 years
- Gender
- Both males and females
Description
Evaluation criteria Pharmacokinetic assessment with plasma concentrations of proguanil and cycloguanil Safety assessments with adverse event monitoring including subjective/objective symptoms, physical examination, vital signs, electrocardiogram, and laboratory tests
Evaluation criteria Pharmacokinetic assessment with plasma concentrations of proguanil and cycloguanil Safety assessments with adverse event monitoring including subjective/objective symptoms, physical examination, vital signs, electrocardiogram, and laboratory tests
Tracking Information
- NCT #
- NCT04568772
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: SeungHwan Lee, MD, PhD Seoul National University Hospital
Get Well Soon